Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions.

PURPOSE The aim of this study was to determine the incidence of invasive breast carcinoma in patients with preoperative diagnosis of ductal carcinoma in situ (DCIS) by stereotactic vacuum-assisted biopsy (SVAB) performed for microcalcification-only lesions, and to identify the predictive factors of invasion. METHODS From 2000 to 2010, the records of 353 DCIS patients presenting with microcalcification-only lesions who underwent SVAB were retrospectively reviewed. The mammographic size of microcalcification cluster, presence of microinvasion within the cores, the total number of calcium specks, and the number of calcium specks within the retrieved core biopsy specimen were recorded. Patients were grouped as those with or without invasion in the final pathologic report, and variables were compared between the two groups. RESULTS The median age was 58 years (range, 34-88 years). At histopathologic examination of the surgical specimen, 63 of 353 patients (17.8%) were found to have an invasive component, although SVAB cores had only shown DCIS preoperatively. The rate of underestimation was significantly higher in patients with microcalcification covering an area of 40 mm or more, in the presence of microinvasion at biopsy, and in cases where less than 40% of the calcium specks were removed from the lesion. CONCLUSION Invasion might be underestimated in DCIS cases diagnosed with SVAB performed for microcalcification-only lesions, especially when the mammographic size of calcification is equal to or more than 40 mm or if microinvasion is found within the biopsy specimen and less than 40% of the calcifications are removed. At least 40% of microcalcification specks should be removed from the lesion to decrease the rate of underestimation with SVAB.

[1]  Y. Sim,et al.  Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme. , 2015, Clinical radiology.

[2]  P. Orsaria,et al.  Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review , 2012, International journal of surgical oncology.

[3]  M. Wallis,et al.  Quantification of the UK 5-point breast imaging classification and mapping to BI-RADS to facilitate comparison with international literature. , 2011, The British journal of radiology.

[4]  L. Wilkinson,et al.  The practical application of the UK 5-point scoring system for breast imaging: how standardisation of reporting supports the multidisciplinary team. , 2011, The British journal of radiology.

[5]  Hee Jung Shin,et al.  Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features. , 2008, AJR. American journal of roentgenology.

[6]  D. Giri,et al.  Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy. , 2007, AJR. American journal of roentgenology.

[7]  S. Ciatto,et al.  Underestimation of malignancy of breast core‐needle biopsy , 2007, Cancer.

[8]  R. J. Jackman,et al.  Breast microcalcifications: retrieval failure at prone stereotactic core and vacuum breast biopsy--frequency, causes, and outcome. , 2006, Radiology.

[9]  K. Linnau,et al.  Stereotactic 11-gauge vacuum-assisted breast biopsy: influence of number of specimens on diagnostic accuracy. , 2004, Radiology.

[10]  L. Liberman,et al.  To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? , 2002, AJR. American journal of roentgenology.

[11]  S. Goodman,et al.  Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices. , 2001, Radiology.

[12]  W. P. Evans,et al.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. , 2001, Radiology.

[13]  Darrell N. Smith,et al.  Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. , 2000, AJR. American journal of roentgenology.

[14]  C. Lee,et al.  Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? , 2000, Radiology.

[15]  C. Lee,et al.  Underestimation of breast cancer with II-gauge vacuum suction biopsy. , 2000, AJR. American journal of roentgenology.

[16]  V. Jackson,et al.  Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. , 1999, AJR. American journal of roentgenology.

[17]  R. J. Jackman,et al.  Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. , 1999, Radiology.

[18]  L. Liberman,et al.  Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. , 1998, Radiology.

[19]  F. Tavassoli,et al.  Mammary ductal carcinoma in Situ with microinvasion , 1998, Cancer.

[20]  L. Liberman,et al.  Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy. , 1998, Radiology.

[21]  T. Krebs,et al.  Evaluation of 14- and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model. , 1997, Radiology.

[22]  S. Pinder,et al.  Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. , 1994, AJR. American journal of roentgenology.

[23]  I. Ellis,et al.  Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. , 1994, Radiology.

[24]  D. Ikeda,et al.  Ductal carcinoma in situ: atypical mammographic appearances. , 1989, Radiology.

[25]  H. Gallager,et al.  Intraductal carcinoma of the breast. A comparative study. , 1975, American journal of surgery.

[26]  W. Yang,et al.  Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. , 2004, AJR. American journal of roentgenology.